Association of equine gammaherpesvirus-5 with facial lymphohistiocytic interface dermatitis in seven adult horses from the United States.

The research article showcases a study that associates Equine herpesvirus-5 (EHV-5) to a skin condition called facial lymphohistiocytic interface dermatitis found in seven adult horses in the United States.

Context and Objectives

• EHV-5 is a virus prevalent in healthy horses across the globe but its role in causing diseases had not been conclusively established.
• The research aimed to explore the presence and impact of this virus in horses diagnosed with equine interface dermatitis, a skin condition. The researchers put emphasis on case studies from the New York State Animal Health Diagnostic Center and the Oregon Veterinary Diagnostic Laboratory.

Methodology

• The researchers identified ten cases of equine interface dermatitis from the New York Center’s database (from 2007 to 2022) and closely examined them for signs of the virus.
• Additionally, two similar cases were identified at the Oregon Veterinary Diagnostic Laboratory.
• The team observed characteristics such as irregular, non-painful spots on the face, hydropic degeneration, and pigmentary incontinence, among others, to establish links with the virus.
• The presence of EHV-5 was confirmed through methods such as quantitative polymerase chain reaction (qPCR), in situ hybridization, and electron microscopy.

Findings and Conclusion

• Seven horses showed signs of the virus and were confirmed to have EHV-5 through laboratory tests.
• The virus was not detected in five control horses and five other horses diagnosed with the skin condition but without the histologic evidence of the virus.
• Significantly, one of the seven horses developed Equine Multinodular Pulmonary Fibrosis (EMPF) and had to be euthanized, further strengthening the potential relationship between EHV-5 and specific diseases.
• The researchers concluded that these were the first documented cases of facial interface dermatitis associated with EHV-5 in the United States, thus potentially opening up new areas of study into the virus’s impact on health conditions in horses.